Experimental studies have revealed that the intracellular pathways ERK/MEK, Akt-mTOR, NF-kB, WNT and JAK/STAT are involved in the regulation of PD-L1 in prostate cancer. This evidence concerns the gene AKT1 and prostate carcinoma.